ImageneBio, Inc. (IMA) stock

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$3.45−0.27 (-7.26%)

Close on Nov 12, 2026Market cap $39.16MP/E –Yield –

ImageneBio cash

Cash and short-term investments held at the end of each period.

ImageneBio's cash was $126.60M at Sep 30, 2026. For fiscal 2025 it was $135.35M, up 1016.9% from the year before. The highest annual figure on record is $233.09M in fiscal 2021.

Annual cash

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$135.35M	+1016.9%
FY2024	Dec 31, 2024	$12.12M	-93.1%
FY2023	Dec 31, 2023	$175.50M	+11.9%
FY2022	Dec 31, 2022	$156.90M	-32.7%
FY2021	Dec 31, 2021	$233.09M	+42.7%
FY2020	Dec 31, 2020	$163.36M	+99.0%
FY2019	Dec 31, 2019	$82.08M	–

Quarterly cash

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$126.60M	-11.2%
Q2 FY2026	Jun 30, 2026	$136.20M	+214.0%
Q1 FY2026	Mar 31, 2026	$117.20M	+42.6%
Q4 FY2025	Dec 31, 2025	$135.35M	+1016.9%
Q3 FY2025	Sep 30, 2025	$142.58M	+40.4%
Q2 FY2025	Jun 30, 2025	$43.37M	-70.2%
Q1 FY2025	Mar 31, 2025	$82.21M	-47.8%
Q4 FY2024	Dec 31, 2024	$12.12M	-93.1%
Q3 FY2024	Sep 30, 2024	$101.57M	-48.4%
Q2 FY2024	Jun 30, 2024	$145.42M	-7.6%
Q1 FY2024	Mar 31, 2024	$157.35M	+14.2%
Q4 FY2023	Dec 31, 2023	$175.50M	+11.9%
Q3 FY2023	Sep 30, 2023	$196.93M	+12.9%
Q2 FY2023	Jun 30, 2023	$157.31M	-18.4%
Q1 FY2023	Mar 31, 2023	$137.81M	-35.1%
Q4 FY2022	Dec 31, 2022	$156.90M	-32.7%
Q3 FY2022	Sep 30, 2022	$174.36M	-29.1%
Q2 FY2022	Jun 30, 2022	$192.81M	-27.0%
Q1 FY2022	Mar 31, 2022	$212.38M	-24.4%
Q4 FY2021	Dec 31, 2021	$233.09M	+42.7%
Q3 FY2021	Sep 30, 2021	$245.90M	+340.2%
Q2 FY2021	Jun 30, 2021	$264.00M	+315.6%
Q1 FY2021	Mar 31, 2021	$281.01M	+289.7%
Q4 FY2020	Dec 31, 2020	$163.36M	+99.0%
Q3 FY2020	Sep 30, 2020	$55.86M	–
Q2 FY2020	Jun 30, 2020	$63.53M	–
Q1 FY2020	Mar 31, 2020	$72.11M	–
Q4 FY2019	Dec 31, 2019	$82.08M	–